News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aeris Therapeutics, Inc. Bolsters Executive Management Team with Key Appointments for Initial Commercialization of Advanced Emphysema Therapy



6/28/2011 10:56:02 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aeris Therapeutics, LLC today announced the appointments of Dennis D’Oria as its new Vice President of International Sales and Marketing and Mr. Charles R. Carter as Chief Financial Officer. “Aeris has made great strides in the development phase of the AeriSeal® System,” said David Dove, M.D., President and CEO. “Dennis and Charley bring a great deal of combined experience that will enable us to drive our commercialization efforts. We are eager to make the clinical benefits of the AeriSeal System available to as many patients suffering with advanced emphysema as possible.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES